{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:04:02Z","timestamp":1648980242686},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/naika.102.738","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T01:46:22Z","timestamp":1394415982000},"page":"738-744","source":"Crossref","is-referenced-by-count":0,"title":["Drug Allergy for Physicians to Know-severe Cutaneous Drug Eruptions-"],"prefix":"10.2169","volume":"102","author":[{"given":"Yoko","family":"Kano","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kyorin University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1"},{"key":"2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chung WH, et al: Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14: 1343-1350, 2008.","DOI":"10.1038\/nm.1884"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Takahashi R, et al: Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 182: 8071-8079, 2009.","DOI":"10.4049\/jimmunol.0804002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shiohara T, et al: Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy 97: 122-138, 2012.","DOI":"10.1159\/000335624"},{"key":"6","unstructured":"6) Roujeau JC, et al: Telaprevir-related dermatitis. Arch Dermatol 2012 Nov 19: 1-7. doi: 10. 1001\/jamadermatol. 2013. 938. [Epub ahead of print]."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Asano Y, et al: Cytomegalovirus disease during the course of severe drug eruptions: report of two cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol 145: 1030-1036, 2009.","DOI":"10.1001\/archdermatol.2009.195"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shiohara T, et al: Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruption and those under immunosuppressive therapy. Allergol Int 59: 333-343, 2010.","DOI":"10.2332\/allergolint.10-RAI-0260"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kano Y, et al: Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin North Am 94: 743-759, 2010.","DOI":"10.1016\/j.mcna.2010.03.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Onuma H, et al: High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome. J Clin Endocrinol Metab 2012 Oct 15. [Epub ahead of print].","DOI":"10.1210\/jc.2012-2054"},{"key":"11"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/3\/102_738\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:59:34Z","timestamp":1621443574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/3\/102_738\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.102.738","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}